The endothelial cells of tumor blood vessels have a net negative charge [49], which helps KLA peptides target tumor tissues or cells: the lysine residues on the positively charged KLA can interact with the cells via electrostatic interactions, hydrogen bonding, and hydrophobic forces, thereby facilitating uptake [38,39]. The gene discussed is KL; the disease is neoplasm.